STAAR Surgical shares fall 1.01% after-hours as Broadwood Partners opposes Alcon's acquisition.

STAAR Surgical Company declined 1.01% in after-hours trading, with the company's largest shareholder, Broadwood Partners, announcing its intention to vote against Alcon's proposed acquisition. Broadwood Partners, which holds a 27.5% stake in STAAR, expressed disappointment with the board's decision to sell the company without pursuing an adequate sale process. The investment firm also highlighted that the offer did not reflect STAAR's recent financial improvements and urged the company to reconsider its recommendation of the offer.